A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Clinical trial NCT06441812 · RECRUITING
Trial details
- NCT number
- NCT06441812
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-19
- Primary completion
- 2028-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.